Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 351 - 400 out of 11,275

Document Document Title
WO/2010/081163A2
Method for selective 2-sulfation of glycosides.  
WO/2010/081163A3
Method for selective 2-sulfation of glycosides.  
WO/2010/073126A3
Conjugate compounds comprising saccharides coupled to bioreductively activated drugs that permeate cell membranes via specific hypoxia- upregulated transporters in hypoxic cells and retain cytotoxic and rediosensitizmg activities. They a...  
WO/2010/073126A2
Described herein are compounds that permeate cell membranes via specific hypoxia-upregulated transporters in hypoxic cells, get bioreductively activated intracellularly, and bind selectively to subcellular macromolecules to demonstrate h...  
WO/2010/072754A1
The invention relates to [6)-O-α-D-Glcp→]1 →]n-6-O-β-D-Glcp-(1→-phenolic derivatives. These [6)-O-α-D-Glcp-(1→]n-6-O-β-D-Glcp-(1→-phenolic derivatives of selected phenolics are new, have a solubility in water higher than th...  
WO/2010/071824A3
Among other things, the present disclosure provides methods for enriching, identifying, and/or quantifying unusually modified glycans (e.g., phosphorylated glycans, sulfated glycans, and/or multi-acetylated glycans). In many embodiments,...  
WO/2010/071824A2
Among other things, the present disclosure provides methods for enriching, identifying, and/or quantifying unusually modified glycans (e.g., phosphorylated glycans, sulfated glycans, and/or multi-acetylated glycans). In many embodiments,...  
WO/2010/067010A3
The invention relates to derivatives of morphine-6-glucuronide having formula (I) wherein R1 is a 5-membered heteroaromatic group optionally substituted by one or more substituents selected from among halogen atoms and (C1-C4)alkyl, halo...  
WO/2010/066909A3
The present invention relates in general to a compound which is characterized by a formula selected from the following formulas A, B, C, D, E or F; or a pharmaceutically acceptable salt thereof. The present invention further relates to p...  
WO/2010/067010A2
The invention relates to derivatives of morphine-6-glucuronide having formula (I) wherein R1 is a 5-membered heteroaromatic group optionally substituted by one or more substituents selected from among halogen atoms and (C1-C4)alkyl, halo...  
WO/2010/067008A2
The invention relates to compounds having formula (I) wherein: R1 represents a hydrogen atom or a (C1-C4)alkyl group; R2 represents a hydroxyl group, a thiol group, a (C1-C4)alkyloxy group or a thio(C1-C4)alkyl group; and n is an integer...  
WO/2010/067007A2
The invention relates to a method for preparing morphine-6-glucuronide or one of the derivatives thereof, comprising the following steps: (i) reacting a compound having formula (I), wherein R1 represents a carbonyl group, COR5CO or S02R6...  
WO/2010/066909A2
The present invention relates in general to a compound which is characterized by a formula selected from the following formulas A, B, C, D, E or F; or a pharmaceutically acceptable salt thereof. The present invention further relates to p...  
WO/2010/067007A3
The invention relates to a method for preparing morphine-6-glucuronide or one of the derivatives thereof, comprising the following steps: (i) reacting a compound having formula (I), wherein R1 represents a carbonyl group, COR5CO or S02R6...  
WO/2010/067008A3
The invention relates to compounds having formula (I) wherein: R1 represents a hydrogen atom or a (C1-C4)alkyl group; R2 represents a hydroxyl group, a thiol group, a (C1-C4)alkyloxy group or a thio(C1-C4)alkyl group; and n is an integer...  
WO/2010/064172A3
The invention concerns compounds DLBS1425E2.2 and DLBS1425F1 isolated and identified from the extract of the plant Phaleria macrocarpa (Scheff.) Boerl. The invention also relates to the use of said compounds, either as a single active co...  
WO/2010/062197A1
Processes for obtaining a ganglioside-enriched extract or one or more gangliosides from a ganglioside-containing lipid composition (GCLC) are disclosed. The processes comprise: (a) mixing a GCLC with one or more C4-C10 alcohols and water...  
WO/2010/058130A1
The invention relates to the methyl pentasaccharide O-2,3,4-tri-O-methyl-α-D-glucopyranosyl-(1 →4)-O-2,3-di-O-methyl-β-D-glucopyranosyluronic acid-(1 →4)-O-α-D-glucopyranosyl-(1 →4)-O-2,3-di-O-méthyl-α-L-idopyranosyluronic aci...  
WO/2010/055898A1
An n-type semiconductor composed of a fullerene compound represented by formula (1), which can provide an n-type semiconductor material which is soluble in an organic solvent and capable of providing a uniform thin film. (In the formula,...  
WO/2010/050413A1
Provided is an efficient method for producing a glycolipid biosurfactant, particularly a lactonic sophorose lipid at a low cost, wherein the method includes culturing a microorganism which produces the biosurfactant by limiting oxygen su...  
WO/2010/049751A1
The invention relates to lipochitooligosaccharides obtainable from arbuscular mycorrhizal fungi, and which are useful for stimulating arbuscular mycorrhizal symbiosis, and lateral root formation.  
WO/2010/043049A1
The invention relates to improvements in the field of drug delivery. More particularly, the invention relates to polypeptides having a hydrolyzable covalent bond to a therapeutic agent that includes, etoposide, etoposide 4'- dimethylglyc...  
WO/2010/042851A1
Compounds having antibacterial activity are disclosed. The compounds have the following structure (I): (I) including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, R1, R2 and R3 are as defined here...  
WO/2010/042850A1
Compounds having antibacterial activity are disclosed. The compounds have the following structure (I):(I) including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, R1, R2 and R3 are as defined herei...  
WO/2010/041746A1
Disclosed is a Helicobacter pylori bacterium proliferation inhibitor which comprises a compound capable of inhibiting the proliferation of a Helicobacter pylori bacterium specifically, does not produce any bacterium that is resistant to ...  
WO/2010/038911A1
Nobel Stevia Sweetening components are provided. Through the analysis of the components of the nobel Steviol Glycoside included in the stevia extract and/or crystals, not only the quality control of sweeteners, but judgment on the correc...  
WO/2010/037179A1
The invention relates to anionic conjugates of glycosylated bacterial metabolites that may be used to mimic the structure and/or activity of the anionic bioactive molecules known as glycosaminoglycans (GAGs). The invention also relates t...  
WO/2010/037180A1
The invention relates to anionic oligosaccharide conjugates that may be used to mimic the structure and/or activity of the anionic bioactive molecules known as glycosaminoglycans (GAGs).  
WO/2010/038911A4
Nobel Stevia Sweetening components are provided. Through the analysis of the components of the nobel Steviol Glycoside included in the stevia extract and/or crystals, not only the quality control of sweeteners, but judgment on the correc...  
WO/2010/039159A1
A crystalline form of epirubicin hydrochloride, named herein as 'type II' crystalline epirubicin hydrochloride, has excellent thermal stability. Type II crystalline epirubicin hydrochloride has a powder X-ray diffraction pattern having a...  
WO/2010/032154A2
A ganglioside or a mixture of gangliosides, isolated from the peripheral and central nervous system of a bird, in particular a parrot, their use for the preparation of a medicament, methods for the diagnosis of Proventricular Dilatation ...  
WO/2010/032154A3
A ganglioside or a mixture of gangliosides, isolated from the peripheral and central nervous system of a bird, in particular a parrot, their use for the preparation of a medicament, methods for the diagnosis of Proventricular Dilatation ...  
WO/2010/032154A4
A ganglioside or a mixture of gangliosides, isolated from the peripheral and central nervous system of a bird, in particular a parrot, their use for the preparation of a medicament, methods for the diagnosis of Proventricular Dilatation ...  
WO/2010/030690A1
The present invention is directed to aminoglycoside compounds of general formula (I) as well as their preparation and use as prophylactic or therapeutics against microbial infection.  
WO/2010/030012A1
Disclosed are a novel esterified α-galactosylceramide which is effective for the treatment of cancer or the like, and a pharmaceutical preparation comprising the esterified α-galactosylceramide. Specifically disclosed is a compound rep...  
WO/2010/028487A1
The instant application is directed to bidesmosidic betulin and betulinic acid saponin derivatives of formula (I), and use thereof as antitumor agents. In particular, said compounds are effective in treating lung carcinomas, colorectal a...  
WO/2010/030704A3
Compounds having antibacterial activity are disclosed. The compounds have the following structure (I) including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, Z1, Z2, Z3, Z4, R1, R2 and R3 are as d...  
WO/2010/029185A1
A compound of the following formula or a salt, solvate or formula (I) and a pharmaceutical composition containing said compound. It concerns also its use in the treatment of cancer and/or of pathological angiogenesis and/or in promoting ...  
WO/2010/027108A1
Disclosed are a method for sensing saccharide-binding protein easily, quickly, and with high sensitivity, and a fluorescent compound necessary for this sensing. Specifically, disclosed is a method for sensing saccharide-binding protein t...  
WO/2010/023162A1
A new process for extracting and purifying glucosinolates from plant material, preferably broccoli sprouts or seeds is described. An alcoholic extract is adsorbed onto a basic resin and eluted with ammonia. Optionally, the alcoholic extr...  
WO/2010/023594A1
Compounds of Formula (I) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by sodium-glucose transporter inhibitors (in particular, SGLT2 inhibitors).The compounds disclosed her...  
WO/2010/018474A2
The invention relates to a novel ester, the 3,5-di-tertiobutyl-4-hydroxybenzoate of 3,4,5-trihydroxy-6-methoxytetrahydropyran-2-yl methyl defined by the following formula (I). The invention also relates to the method for preparing the co...  
WO/2010/018474A3
The invention relates to a novel ester, the 3,5-di-tertiobutyl-4-hydroxybenzoate of 3,4,5-trihydroxy-6-methoxytetrahydropyran-2-yl methyl defined by the following formula (I). The invention also relates to the method for preparing the co...  
WO/2010/018438A3
The invention relates to the tetrazole glycosides derivatives, which are inhibitors of Sodium dependent glucose co transporter (SGLT), particularly SGLT2 and method of treating diseases, conditions and/or disorders inhibited by SGLT2 wit...  
WO/2010/018435A1
The invention relates to the O-glucosylated amide derivatives, which are inhibitors of Sodium dependent glucose co transporter (SGLT), particularly SGLT2 and method of treating diseases, conditions and/or disorders inhibited by SGLT2 wit...  
WO/2010/014814A2
The present invention discloses a set of glycosylated warfarin analogs which are useful as anti-tumor or anti-metastatic agents and as reagents for studying sugar uptake in cells.  
WO/2010/014814A8
The present invention discloses a set of glycosylated warfarin analogs which are useful as anti-tumor or anti-metastatic agents and as reagents for studying sugar uptake in cells.  
WO/2010/014814A3
The present invention discloses a set of glycosylated warfarin analogs which are useful as anti-tumor or anti-metastatic agents and as reagents for studying sugar uptake in cells.  
WO/2010/005560A3
Phytoplankton represent a potential source of bioactive compounds. The present disclosure provides, inter alia, methods for identifying glycerolipids and apoptosis- inducing sphingosine-like lipids from virally-infected phytoplankton.  
WO/2010/004433A3
Hydrophobically enhanced aminoglycosides have been prepared and shown to be effective antibacterial agents. These agents may be used in the treatment or prevention of various bacterial infections. Methods of preparing these agents also p...  

Matches 351 - 400 out of 11,275